ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NEJM publishes second successful Epidiolex trial in LGS
pharmatimes
July 12, 2018The New England Journal of Medicine has published the second of two late stage studies showing that GW Pharma’s cannabinoid Epidiolex cut seizures in patients with the rare childhood epilepsy Lennox-Gastaut Syndrome.
Pharma Sources Insight January 2025
